HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antimicrobial resistance report

This article was originally published in The Rose Sheet

Executive Summary

Antimicrobial Resistance Interagency Task Force presents second 1annual progress report on a public health action plan to combat antimicrobial resistance during a meeting June 25 in Bethesda, Md. Second annual report focuses on domestic issues, such as implementing a national antimicrobial resistance surveillance plan. Interagency task force includes Centers for Disease Control and Prevention, FDA and National Institutes of Health. Evaluation of benefits and risks in consumer products such as soap were included in action plan unveiled by HHS in 2001 (2"The Rose Sheet" Jan. 22, 2001, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011314

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel